Treatment effects of alprazolam and imipramine: Physiological versus subjective changes in patients with generalized anxiety disorder
Open Access
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 28 (10) , 849-861
- https://doi.org/10.1016/0006-3223(90)90567-l
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Cardiac symptoms and anxiety disorders: Contributing factors and pharmacologic treatmentThe American Journal of Cardiology, 1987
- Self-report and cardiovascular measures of arousal: Fractionation during residual arousalBiological Psychology, 1987
- Imipramine and Chlordiazepoxide in Depressive and Anxiety DisordersArchives of General Psychiatry, 1986
- Platelet α2-Adrenergic Receptor Binding and Plasma CatecholaminesArchives of General Psychiatry, 1984
- Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled studyPsychopharmacology, 1982
- Publication Recommendations for Electrodermal MeasurementsPsychophysiology, 1981
- Patterns of desynchrony in agoraphobia: A preliminary reportBehaviour Research and Therapy, 1980
- The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations.Circulation, 1979
- Measuring Baseline‐Treatment Differences in Heart Rate Variability: Variance versus Successive Difference Mean Square and Beats per Minute versus Interbeat IntervalsPsychophysiology, 1979
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959